FDA approved Tauvid for IV injection, the first drug used to help image a distinctive characteristic of Alzheimer’s disease in the brain called tau pathology. Tauvid is a radioactive diagnostic agent for adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease.
Read more: FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease